Health Press Release – Weekly Newsletter for February 1-7, 2011
Monday, February 7, 2011
AMT Receives EUR 1.1 Million Funding for Acute Intermittent Porphyria Gene Therapy as part of EU Consortium Grant
AMSTERDAM, The Netherlands, January 31, 2011 – Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, announced today that the European Union (EU)
has finalized a EUR 3.3 million grant to the AIPGENE consortium, of which AMT
is a member, for the development of a gene therapy product for Acute
Intermittent Porphyria (AIP). …. Source : Gaea News Network.
Another Standing Ovation for The King’s Speech
MEMPHIS, Tennessee, January 31, 2011 – Jane Fraser, president, The Stuttering Foundation
(www.stutteringhelp.org), issued the following reaction to tonight's
"SAG Awards":
"It is our privilege to give The King's Speech another standing ovation
for bringing hope and understanding to those who stutter. With its
much-deserved two SAG Awards, Best Male Actor in a Leading Role … Original source on Gaea Times at : Another Standing Ovation for The King's Speech.
Verona Pharma Applies for Approval to Test RPL554 in UK Clinical Trials
LONDON, January 31, 2011 – Verona Pharma plc (AIM:VRP.L) the biotechnology company dedicated to
discovering new drugs for the treatment of chronic respiratory diseases, has
applied to the Medicines and Healthcare Products Regulatory Agency (MHRA),
the Governmental agency in the UK with responsibility for standards of
safety, quality and performance of new drug treatments, to conduct clinical
trials in …. Source article on Gaea Times at : Verona Pharma Applies for Approval to Test RPL554 in UK Clinical Trials.
Hold Your Own ‘Thinner Party’ to Save Pennies and Lose Pounds This January
New Look alli Website Full of Healthy Recipes to Cook You and Your Friends Slim
LONDON, January 31, 2011 – January is traditionally the month we all tighten our belts, whether that
means cutting down on the nights out to save a few pennies, or swapping mince
pies for muesli to lose a few pounds – or …. Original article : Hold Your Own 'Thinner Party' to Save Pennies and Lose Pounds This January.
Hoya Announces Third Quarter Financial Results
TOKYO, January 31, 2011 – HOYA Corporation today announced financial results for the third quarter
ended December 31, 2010. Net sales were up 1.5% to 108,449 million yen
year-on-year, and operating income rose 4.7% to 19,897 million yen. Net
income was up 12.0% to 13,210 million yen, and earnings per share were 30.62
yen compared with 27.24 yen …. Original source : Hoya Announces Third Quarter Financial Results.
Bill Gates Releases Third Annual Letter, Calling for Sustained Foreign Aid to Boost Global Health and Development
Speaking at Historic Roosevelt House, Gates Outlines Why the World Should Prioritize Vaccines and the Eradication of Polio
NEW YORK, January 31, 2011 – Bill Gates, co-chair of the Bill & Melinda Gates Foundation, argues the
case for polio eradication and expanded childhood immunization in his third
annual letter released today. The letter, a personal account of … Original article on : Bill Gates Releases Third Annual Letter, Calling for Sustained Foreign Aid to Boost Global Health and Development.
Abbott’s TREK(R) Coronary Balloon System Now Available in the United States and Japan
With Previous CE Mark in Europe, the TREK Balloon Dilatation Catheter System is Now Available in All Major Markets Worldwide
ABBOTT PARK, Illinois, January 31, 2011 – Abbott (NYSE: ABT) today announced it has received regulatory clearance
in the United States and approval in Japan for its TREK(R) and MINI-TREK(TM)
Coronary Dilatation Catheters for the treatment of … Read more >>.
Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator
GREENWICH, Connecticut, January 31, 2011 – Mederi Therapeutics Inc. announced today that it has received FDA 510(k)
clearance for its new MDRF1 Generator.
The Mederi RF Generator powers the Stretta(R) System for treatment of
Gastroesophageal Reflux Disease (GERD) as well as the Secca(R) System for
Bowel Incontinence or Bowel Control Disorder (BCD).
…. Source article on Gaea Times at : Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator.
The Global Pharmaceutical Market is Expected to Mature to $220 Billion by 2016, in Spite of the Inclement Effects of the Healthcare Reform Bill
Biopharmaceutical Market Worldwide is Set for High Growth.
DALLAS, February 1, 2011 – The US biopharmaceutical market which has previously contributed 60% of
world market share will witness a sudden growth spurt, triggered by a spate
of policy changes, grants and the recent Health Care Reform Bill and AARC.
However, as the rest of …. Original source : The Global Pharmaceutical Market is Expected to Mature to $220 Billion by 2016, in Spite of the Inclement Effects of the Healthcare Reform Bill.
Simbionix Launches MentorLearn: Providing the Optimal Solution for Training Program Management
CLEVELAND, February 1, 2011 – Simbionix USA Corporation, the world's leading provider of medical
education and simulation technology, released its new MentorLearn system at
the International Meeting on Simulation in Healthcare (IMSH) last week.
Simbionix's exciting new MentorLearn platform now provides the optimal
solution for managing all training and education needs for the Simbionix …. Original source : Simbionix Launches MentorLearn: Providing the Optimal Solution for Training Program Management.
Aircraft Medical Wins Long-running Video Laryngoscope Patent Litigation Against Verathon
Judge Finds Aircraft's McGrath(R) Series 5 Does not Infringe Verathon's "Glidescope" Patent
EDINBURGH, Scotland, February 1, 2011 – Aircraft Medical Ltd ("Aircraft") is pleased to announce that
judgment has been passed in its favour in the long running patent
infringement litigation between it and US rival Verathon Medical Inc.
("Verathon"), a subsidiary of Roper Industries Inc.
… Read more : Aircraft Medical Wins Long-running Video Laryngoscope Patent Litigation Against Verathon.
Optimax Refractive Conference: The Year’s Ultimate Vision Event
Celebrating 20 Years of Laser Eye Surgery
LONDON, February 2, 2011 – Since the early stages of laser eye surgery (
www.optimax.co.uk/treatments_explained.aspx), Optimax have been
bringing the latest procedures to the UK public, and can now look back
proudly at the thousands of lives which have been transformed by their
treatments.
This week, the laser eye … Read the original article on Gaea Times at : Optimax Refractive Conference: The Year's Ultimate Vision Event.
The 2011 Reaxys(R) PhD Prize for Chemistry Research Opens for Entries
NEUCHATEL, Switzerland, February 2, 2011 – Elsevier Properties SA announces the launch of the 2011 Reaxys PhD Prize,
a global competition for candidates currently studying for a PhD or having
completed a PhD within the last 12 months.
The prize will be awarded for original and innovative research in
organic, organometallic and inorganic chemistry … Read more >>.
Elsevier Acquires Oncology Journal Portfolio From Cancer Information Group
Journals Provide the Highest Quality Content Focused on Tumor-Specific Topics That Affect Oncologists and Their Patients
NEW YORK, February 2, 2011 – Elsevier (www.elsevier.com), the leading global
publisher of scientific, technical, and medical information products and
services, announced today that it acquired the oncology portfolio of journals
previously published by CIG Media Group LP., (operated as Cancer Information
Group). …. Source article : Elsevier Acquires Oncology Journal Portfolio From Cancer Information Group.
Bupa’s ‘How are you Britain?’ Report Reveals Rise of Athletic Older People
LONDON, February 2, 2011 – Bupa has revealed that the over-60s are fitter than ever, leaving their
younger counterparts behind when it comes to exercise.
Research from the Bupa 'How are you Britain?' report reveals that UK
residents who are 60 plus are three times more likely to exercise every day
than those in …. Source article on Gaea Times at : Bupa's 'How are you Britain?' Report Reveals Rise of Athletic Older People.
VWR International, LLC Acquires AMRESCO Inc.
Acquisition Provides VWR Life Science Customers Even Greater Choice and Value
RADNOR, Pennsylvania, February 2, 2011 – VWR International, LLC, a global leader in distributing laboratory
supplies and services, announced today that it has acquired AMRESCO Inc., a
manufacturer and supplier of high quality biochemicals and reagents for
Molecular Biology, Life Sciences, Proteomics, Clinical and Histology areas of
research …. Source article on Gaea Times at : VWR International, LLC Acquires AMRESCO Inc..
Pharmaceutical Industry Bracing for Record Patent Expiries, EvaluatePharma Data Reveals
LONDON, February 2, 2011 – Thirteen US blockbusters will lose patent protection over the
next two years, data from EvaluatePharma show, highlighting the challenges
facing the pharmaceutical industry in the coming years. With the reporting
season in full swing it is no wonder that several big pharmaceutical company
chief executives have warned of tough times ahead.
Trimega Laboratories Showcased to Promote Manchester’s Life Science Industry to European Investors
LONDON, February 2, 2011 – Trimega Laboratories, the leading hair alcohol and drug testing company,
is to be one of a few Manchester businesses in the life science sector to
promote their success on the European stage to encourage further investment
in the city.
On Wednesday 2 February, Trimega will host 10 journalists from … Original article on : Trimega Laboratories Showcased to Promote Manchester's Life Science Industry to European Investors.
Digna Biotech and CIMA Receive EUR 1.3 Million Funding for Acute Intermittent Porphyria Gene Therapy as Part of an EU FP7 Grant for Clinical Development of Orphan Drugs
MADRID, February 3, 2011 – Digna Biotech and the Centro de Investigaci??n M??dica Aplicada (CIMA) de
la Universidad de Navarra announced today that the European Union (EU) has
finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and
CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million
respectively for the clinical …. Original article on Gaea Times at : Digna Biotech and CIMA Receive EUR 1.3 Million Funding for Acute Intermittent Porphyria Gene Therapy as Part of an EU FP7 Grant for Clinical Development of Orphan Drugs.
Cepheid and FIND Announce Collaboration to Develop HIV Viral Load Test
Partnership Expected to Expand Molecular Test Offering in Developing Country Markets
SUNNYVALE, California and GENEVA, February 3, 2011 – Cepheid (Nasdaq: CPHD) and FIND (Foundation for Innovative New
Diagnostics) today announced a new collaboration to accelerate the
development of a rapid molecular test for the measurement of human
immunodeficiency virus (HIV) viral load.
The Xpert(R) …. Source article on Gaea Times at : Cepheid and FIND Announce Collaboration to Develop HIV Viral Load Test.
Spinning for the Upper Body From Virgin Active Health Clubs
Health Club Chain Launches Kranking(R), the Brand New Upper Body Workout From Spinning Creator Jonny G
LONDON, February 3, 2011 – Virgin Active Health Clubs (www.virginactive.co.uk/) is
launching the latest US exercise trend, Kranking(R), into all 71 of its
health clubs nationwide following successful trials in West London and
Sheffield. Innovated by spinning guru, Jonny G, Kranking(R) aims … Read more »»».